Breakthrough Febrile Neutropenia and Associated Complications in Non-Hodgkin’s Lymphoma Patients Receiving Pegfilgrastim

Publisher： Karger

E-ISSN： 1421-9662|125|3|107-114

ISSN： 0001-5792

Source： Acta Haematologica, Vol.125, Iss.3, 2010-11, pp. : 107-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Febrile Neutropenia and Myelotoxicity of Chemotherapy: A Meta-Analysis of Biosimilar G-CSF Studies in Breast Cancer, Lung Cancer, and Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 599-604

Karger

Access to resources Recommend Favorite

Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States

By Lyman Gary   Lalla Anjana   Barron Richard   Dubois Robert W.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite

Antibody Therapy with Rituximab for Patients with Low-Grade Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Is Bone Marrow Biopsy Obligatory in All Patients with Non-Hodgkin’s Lymphoma?

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-05 ,pp. : 61-64

Karger

Access to resources Recommend Favorite

Burden of febrile neutropenia in the Netherlands

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 2, 2015-03 ,pp. : 232-241

John Wiley & Sons Inc

Access to resources Recommend Favorite